Active Biotech AB (Nasdaq Stockholm) carries out a rights offering of SEK 225 million. Vinge advises Active Biotech. The Vinge team primarily consists of Erik Sjöman (partner, capital markets & public M&A) and associates Christian Lindhé, Ludvig Frithiof and Madelene Eriksson.